Atlas Trials

A Trial of Intranasal Remimazolam Pharmacokinetics, Pharmacodynamics, Safety and Bioavailability

Clinical trial NCT03329014 · COMPLETED

Trial details

NCT number
NCT03329014
Sponsor
Paion UK Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Procedural Sedation
Start date
2017-05-15
Primary completion
2017-06-09
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.